Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Terminated 4Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Neoplasms, Squamous Cell 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Adult Solid Neoplasm 1

Interventions

pembrolizumab 22Cisplatin 17Surveys and Questionnaires 9Radiotherapy 8Carboplatin 8Radiotherapy, Intensity-Modulated 7Cetuximab 7Paclitaxel 6Nivolumab 6Drug Therapy 6Radiation 4Fluorouracil 4Taxes 3Docetaxel 3selpercatinib 2dostarlimab 2Yoga 2Surgical Procedures, Operative 2Standard of Care 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Chemoradiotherapy 2Blood Specimen Collection 2ALX148 2veliparib 1tisotumab vedotin 1tislelizumab 1palbociclib 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Head and Neck Neoplasms × Erlotinib Hydrochloride × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡